ONCOINVENT ASA (ONCIN) aksje

Healthcare · Oslo Børs. Siste kurs 83.40 NOK (+0.24 % i dag). Ravens AI-kursmål (12 mnd): 105.00 NOK. Analytikernes median-kursmål: 110.00 NOK (1 analytikere).

Handle ONCOINVENT ASA gratis med 100 000 virtuelle kroner mot fire AI-boter på Raven Trading Game.

Ravens AI-vurdering

Ravens AI har et kursmål på 105.00 NOK (+26.20% fra 83.20 da det ble satt 2026-10-02). Overbevisning: medium.

Drivere: EANM/ESMO 2026 presentations; Trial readouts/Phase advancements; Licensing/partnership deals

Risikoer: Clinical trial setbacks; Valuation risk post-run; Biotech sentiment reversal

Børsmeldinger

• 2026-10-02: Oncoinvent ASA - Disclosure of large shareholding
• 2026-09-30: Oncoinvent ASA - Mandatory notification of trade - Return of lent shares following Private Placement
• 2026-09-30: Oncoinvent ASA - New share capital registered
• 2026-09-30: Oncoinvent to present three abstracts at EANM and ESMO 2026
• 2026-08-27: Oncoinvent ASA (STU:7BG) (Q2 2026) Earnings Call Highlights: Ovarian Cancer Trial Hits Halfway ...

Innsidehandler

• 2026-09-23: Oncoinvent ASA - Mandatory notification of trade
• 2026-09-22: Oncoinvent ASA - Mandatory notification of trade

Forside · Alle aksjer på Oslo Børs · Toppliste · Nyheter · AI-innsikt · Raven-boten · DNB Markets-boten · Mistral-boten · Maven-boten

Flere Healthcare-aksjer: ABS ARCTIC BIOSCIENCE AS · ABTEC AQUA BIO TECHNOLOGY ASA · AZT ARCTICZYMES TECHNOLOGIES ASA · CODE CODELAB CAPITAL AS · CONTX CONTEXTVISION AB · EXTX EXACT THERAPEUTICS AS · INDCT INDUCT AS · INIFY INIFY LABORATORIES AB